| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutics | Director | Class A ordinary shares, par value $0.0001 per share | 171,980 | $9,238,766 | $53.72 | 04 Oct 2024 | Direct |
| MoonLake Immunotherapeutics | Director | Option to Buy | 6,682 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 09:08 |
| MLTX | MoonLake Immunotherapeutics | 04 Oct 2024 | 1 | -$9,186,120 | 4 | Director | 08 Oct 2024, 16:01 |
| MLTX | MoonLake Immunotherapeutics | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:59 |
| MLTX | MoonLake Immunotherapeutics | 01 Oct 2023 | 3 | $0 | 4 | Director | 03 Oct 2023, 19:34 |
| MLTX | MoonLake Immunotherapeutics | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:57 |
| MLTX | MoonLake Immunotherapeutics | 06 Apr 2022 | 1 | $0 | 4 | Director | 05 May 2022, 17:51 |
| MLTX | MoonLake Immunotherapeutics | 05 Apr 2022 | 0 | $0 | 3 | Director | 15 Apr 2022, 16:06 |